Literature DB >> 18490361

Remyelination protects axons from demyelination-associated axon degeneration.

K A Irvine1, W F Blakemore.   

Abstract

In multiple sclerosis, demyelination of the CNS axons is associated with axonal injury and degeneration, which is now accepted as the major cause of neurological disability in the disease. Although the kinetics and the extent of axonal damage have been described in detail, the mechanisms by which it occurs are as yet unclear; one suggestion is failure of remyelination. The goal of this study was to test the hypothesis that failure of prompt remyelination contributes to axonal degeneration following demyelination. Remyelination was inhibited by exposing the brain to 40 Gy of X-irradiation prior to cuprizone intoxication and this resulted in a significant increase in the extent of axonal degeneration and loss compared to non-irradiated cuprizone-fed mice. To exclude the possibility that this increase was a consequence of the X-irradiation and to highlight the significance of remyelination, we restored remyelinating capacity to the X-irradiated mouse brain by transplanting of GFP-expressing embryo-derived neural progenitors. Restoring the remyelinating capacity in these mice resulted in a significant increase in axon survival compared to non-transplanted, X-irradiated cuprizone-intoxicated mice. Our results support the concept that prompt remyelination protects axons from demyelination-associated axonal loss and that remyelination failure contributes to the axon loss that occurs in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490361     DOI: 10.1093/brain/awn080

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  127 in total

1.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

Review 2.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

3.  In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy.

Authors:  Ileana O Jelescu; Magdalena Zurek; Kerryanne V Winters; Jelle Veraart; Anjali Rajaratnam; Nathanael S Kim; James S Babb; Timothy M Shepherd; Dmitry S Novikov; Sungheon G Kim; Els Fieremans
Journal:  Neuroimage       Date:  2016-02-11       Impact factor: 6.556

Review 4.  Neuroprotection and neuroregeneration in multiple sclerosis.

Authors:  Martin Stangel
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

5.  Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells.

Authors:  R Ross Welliver; Jessie J Polanco; Richard A Seidman; Anjali K Sinha; Melanie A O'Bara; Zainab M Khaku; Diara A Santiago González; Akiko Nishiyama; Jurgen Wess; M Laura Feltri; Pablo M Paez; Fraser J Sim
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

6.  The active contribution of OPCs to neuroinflammation is mediated by LRP1.

Authors:  Anthony Fernández-Castañeda; Megan S Chappell; Dorian A Rosen; Scott M Seki; Rebecca M Beiter; David M Johanson; Delaney Liskey; Emily Farber; Suna Onengut-Gumuscu; Christopher C Overall; Jeffrey L Dupree; Alban Gaultier
Journal:  Acta Neuropathol       Date:  2019-09-24       Impact factor: 17.088

Review 7.  Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.

Authors:  Jeffrey K Huang; Stephen P J Fancy; Chao Zhao; David H Rowitch; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

8.  Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.

Authors:  Evelien Houben; Kris Janssens; Doryssa Hermans; Jennifer Vandooren; Chris Van den Haute; Melissa Schepers; Tim Vanmierlo; Ivo Lambrichts; Jack van Horssen; Veerle Baekelandt; Ghislain Opdenakker; Wia Baron; Bieke Broux; Helena Slaets; Niels Hellings
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

9.  Pericytes modulate myelination in the central nervous system.

Authors:  Patrick O Azevedo; Isadora F G Sena; Julia P Andreotti; Juliana Carvalho-Tavares; José C Alves-Filho; Thiago M Cunha; Fernando Q Cunha; Akiva Mintz; Alexander Birbrair
Journal:  J Cell Physiol       Date:  2018-03-01       Impact factor: 6.384

Review 10.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.